Across different drugs and clinical settings, use of PARPi has resulted in a prolonged period without cancer recurrence.
Marla Scott, MD
Advertisement
Articles by Marla Scott, MD
Across different drugs and clinical settings, use of PARPi has resulted in a prolonged period without cancer recurrence.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Psychological and urogenital menopause symptoms similarly burdensome regardless of age at menopause onset
2
Kate McLean, MD, MPH, FACOG: Better understanding bacterial vaginosis
3
Contemporary OB/GYN's top stories from the first half of 2026
4
Air pollution drives greater bone loss in postmenopausal women living in lower-income neighborhoods
5